DAFTAR PUSTAKA
1. Prasad N, Barai S, Gambhir S, et al. Comparison of Glomerular Filtration
Rate Estimation by Plasma Clearance Method with Modification of Diet in
Renal Disease Prediction Equation and Gates method. India Journal of
Nephrology. 2012; 22(2): 103.
2. Dor A, Pauly M, Eichleay MA, Held PJ. End-stage Renal Disease and
Economic Incentives: The International Study of Health Care Organization
and Financing. National Bureau of Economic Research Cambridge, Mass.,
USA; 2007
3. Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure.
Semin Thromb Hemost 2004; 30(5): 579-89
4. Jalal DI, Chonchol M, Targher G: Disorders of hemostasis associated with
chronic kidney disease. Semin Thromb Hemost. 2010; 36(1): 34-40
5. Moal V, Brunet P, Dou L, Morange S, Sampol J, Berland Y. Impaired
expression of glycoproteins on resting and stimulated platelets in uraemic
patients. Nephrol Dial Transplant 2003; 18:1834-41
6. Suresh M; Mallikarjuna RN; Sharan BSM; Hari KB; Shravya KG;
Chandrasekhar M. Hematological Changes in Chronic Renal Failure.
International Journal of Scientific and Research Publication. 2012; 2(9):
1-4
7. Dorgalaleh A, Mahmudi M, Tabibian S, Khatib ZK, Tamaddon G,
Moghaddam ES, et al. Anemia and Thrombocytopenia in Acute and
Chronic Renal Failure. International Journal of Hematology-Oncology and
Stem Cell Research. 2013; 7(4): 34-9
8. Gafter U, Bessler H, Malachi T, Zevin D, Djaldetti M, Levi J. Platelet count
and thrombopoietic activity in patients with chronic renal failure. Nephron.
1987; 45: 201-3
9. Mohamed NMB. Evaluation of Hemostatic Mechanism in Sudanese Renal
Failure’s Patients Admitted to Khartoum Teaching Hospital College of
10.Parikh AM, Spencer FA, Lessard D et al. Venous thromboembolism in
patients with reduced estimated GFR: a populationbased perspective. Am J
Kidney Dis 2011; 58: 746-55
11.Pavord S, Myers B. Bleeding and thrombotic complications of kidney
disease. Blood Rev 2011; 25: 271-8
12.Akinsola A, Durosinmi MO, Akinola NO.The Hematological Profile of
Nigerians with Chronic Renal Failure. Afr J Med Sci. 2000; 29(1): 13-6
13.Islam N, Shah, Jahan S, Badurdduza, Hossain Z. Evaluation of Primary
Screening Test for Platelet Homeostasis in Patients With Chronic Kidney
Disease. Bangladesh J Medicine. 2010; 21: 55-7
14.National Kidney Foundation: K/DOQI Clinical Practice Guidelines for
Anemia of Chronic Kidney Disease. Am J Kidney Dis. 2006; 47 (Suppl 3):
S33-S53.
15.Suwitra K. Penyakit Ginjal Kronik. Dalam: Sudoyo AW, Setiyohadi B,
Alwi I, Simadibrata M, Setiati S (eds). Buku ajar ilmu penyakit dalam jilid
I. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam FKUI. 2009:
1035
16.Oesman F, Setiabudy RD. Fisiologi Hemostasis dan Fibrinolisis. Dalam :
Setiabudy RD. Hemostasis dan Trombosis. Ed 3. Balai Penerbit FKUI.
Jakarta. 2007; 1-8
17.Ikeda Y, Matsubara Y, Kamata T. Platelet Immunology : Structure,
Functions and Polymorphisms of Membrane Glycoproteins. In : Gresele P,
Fuster V, Page JA. et al. Platelets in Hematologic and Cardiovascular
Disorders. Cambridge University Press. UK. 2008; 21-30
18.Miller JL, Rao K. Blood Platelets and von Willebrand Disease. In :
McPherson RA, Pincus MR. Henry`s Clinical Diagnosis and Management
by Laboratory Methods. 21st ed. Elsevier. USA. 2007 : 747-754; 764-765.
19.Calverley DC, Maness LJ. Platelet Function in Hemostasis and Thrombosis.
In : Greer JP, Foerster J, Lukens JN, et al. Wintrobe`s Clinical Hematology.
20.Brass LF, Stalker TJ. Mechanism of Platelet Activation. In : Gresele P,
Fuster V, Page JA. Et al. Platelets in Hematologic and Cardiovascular
Disorders. Cambridge University Press. UK. 2008; 37-48.
21.Michelson AD, Furman MI. Markers of Platelet Activation and Granule
Secretion. In: Quinn M, Fitzgerald D, eds. Platelet Function; Assessment,
Diagnosis and Treatment. New Jersey. Humana Press. 2005:307
22.Colman RW, Hirs J, Marder VJ, Cewes AW, George JN. Hemostasis and
Thrombosis: Basic Principles and Clinical Practice. 4th Edition. Lippincott
and Willkin. Hagerstown. 2002
23.Fogelson A. Computatioin modeling of Blood Clotting: Platelet
Aggregation and Coagulation. Available from:
http://www.ima.umn.edu/biology/whshpabstract/fogelson1.html. 2001.
Dikutip 13 Desember 2014.
24.Rahayuningsih. Agregasi Trombosit. Bagian Patologi Klinik FK UI-RSCM.
1997
25.Kaufman JS, O’Connor TZ, Zhang JH et al. Randomized controlled trial of
clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J
Am Soc Nephrol 2003; 14: 2313–21
26.Glorieux G, Cohen G, Jankowski J et al. Platelet/leukocyte activation,
inflammation, and uremia. Semin Dial 2009; 22: 423–27
27.Di Minno G, Martinez J, McKean ML et al. Platelet dysfunction in uremia.
Multifaceted defect partially corrected by dialysis. Am J Med 1985; 79:
552–9
28.Eknoyan G, Brown CH, 3rd. Biochemical abnormalities of platelets in renal
failure. Evidence for decreased platelet serotonin, adenosine diphosphate
and Mg-dependent adenosine triphosphatase. Am J Nephrol 1981; 1: 17–23
29.Smith MC, Dunn MJ. Impaired platelet thromboxane production in renal
failure. Nephron 1981; 29: 133–7
30.Rabiner SF, Molinas F. The role of phenol and phenolic acids on the
31.Horowitz HI, Stein IM, Cohen BD et al. Further studies on the
platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding.
Am J Med 1970; 49: 336–45
32.Vigano G, Gotti E, Comberti E et al. Hyperparathyroidism does not
influence the abnormal primary haemostasis in patients with chronic renal
failure. Nephrol Dial Transplant 1989; 4: 971–4
33.Mezzano D, Tagle R, Panes O et al. Hemostatic disorder of uremia: the
platelet defect, main determinant of the prolonged bleeding time, is
correlated with indices of activation of coagulation and fibrinolysis. Thromb
Haemost 1996; 76: 312–21
34.Benigni A, Boccardo P, Galbusera M et al. Reversible activation defect of
the platelet glycoprotein IIb-IIIa complex in patients with uremia. Am J
Kidney Dis 1993; 22: 668–76
35.Sreedhara R, Itagaki I, Hakim RM. Uremic patients have decreased
shear-induced platelet aggregation mediated by decreased availability of
glycoprotein IIb–IIIa receptors. Am J Kidney Dis 1996; 27: 355–64
36.Kyrle PA, Stockenhuber F, Brenner B et al. Evidence for an increased
generation of prostacyclin in the microvasculature and an impairment of the
platelet alpha-granule release in chronic renal failure. Thromb Haemost
1988; 60: 205–8
37.Defreyn G, Dauden MV, Machin SJ et al. A plasma factor in uraemia which
stimulates prostacyclin release from cultured endothelial cells. Thromb Res
1980; 19: 695–9
38.Galbusera M, Remuzzi G, Boccardo P. Treatment of bleeding in dialysis
patients. Semin Dial 2009; 22: 279–86
39.Fernandez F, Goudable C, Sie P et al. Low haematocrit and prolonged
bleeding time in uraemic patients: effect of red cell transfusions. Br J
Haematol 1985; 59: 139–48
40.Howard AD, Moore J, Jr,Welch PG et al. Analysis of the quantitative
relationship between anemia and chronic renal failure. Am J Med Sci 1989;
41.Gaarder A, Jonsen J, Laland S et al. Adenosine diphosphate in red cells as
a factor in the adhesiveness of human blood platelets. Nature 1961; 192:
531–2
42.Martin W, Villani GM, Jothianandan D et al. Blockade of
endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by
certain ferrous hemoproteins. J Pharmacol Exp Ther 1985; 233: 679–85
43.Krawczyk W, Dmoszriska A, Sokolowska B. Evaluation of platelet
haemostatis in patients with chronic renal failure. MiadLek. 1994; 47(3-4):
93-9
44.Talwar VK, Gupta HL, Shasinarayan. Clinicohaematological profile in
Chronic renal failure. J Assoc Physicians India. 2002; 50: 22833
45.Aboo O, Seedat YK. Thrombocytopenia in renal failure in developing
country. Nephron. 1987; 45(3): 228-33
46.Tandi M, Mongan A, Manoppo F. Hubungan Antara Derajat Penyakit
Ginjal Kronik dengan Nilai Agregasi Trombosit di RSUP Prof. DR R D
Kandou Manado, Jurnal e-Biomedik. 2014; 2(2)
47.Linthorst GE, Avis HJ, Levi M. Uremic Thrombocytopathy Is not about
